Measuring risk of HIV and HCV among injecting drug users in the Russian federation

European Journal of Public Health

Volumn 19, Issue 4, 2009, Pages 428-433

  Platt, Lucy ^g   Sutton, A J ^a   Vickerman, P ^b,g   Koshkina, E ^c   Maximova, S ^d   Latishevskaya, N ^e   Hickman, M ^b   Bonell, C ^g   Parry, J ^f   Rhodes, T ^g  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c National Centre of Drug Addiction   (Russian Federation)

^d ALTAI STATE UNIVERSITY   (Russian Federation)

^e VOLGOGRAD STATE MEDICAL UNIVERSITY   (Russian Federation)

^f PUBLIC HEALTH ENGLAND   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Force of infection; HIV; Risk of infection; Russia; Surveillance

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; FLUID INTAKE; HEALTH SURVEY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RUSSIAN FEDERATION;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; MODELS, THEORETICAL; POPULATION SURVEILLANCE; RISK ASSESSMENT; RUSSIA; SUBSTANCE ABUSE, INTRAVENOUS; TREPONEMA PALLIDUM; YOUNG ADULT;

EID: 68549136673     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckp041     Document Type: Article

References (42)

1. Hamers FF, Downs AM. HIV in central and eastern Europe. Lancet 2003;361:1035-44 (Review).
2. Rhodes T, Lowndes CM, Judd A, et al. Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia. AIDS 2002;16:F25-31.
3. Rhodes T, Platt L, Maximova S, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: Multi-city study. Addiction 2006;101:252-66.
4. Smolskaya T, Khodakevich LN, Kobyshcha YV, et al. An HIV prevalence study by means of sentinel epidemiological surveillance among injection narcotic abusers in Saint Petersburg. J Microbiol Epidemiol Immunobiol 2000;4:31-3.
5. Federal AIDS Centre. Distribution of HIV positive cases in Russia by main reported risk factor from 1987 to 2004. Federal AIDS Centre, Ministry of Health of the Russian Federation, Moscow, 2007.
6. Feshbach M, Galvin C. HIV/AIDS in Russia - An analysis of statistics. USAID, 2005.
7. Koshkina E. Prevalence of drug addiction diseases in the Russian Federation in 2000 according to official statistics. Voprosy Narkologii (Addiction Issues) 2001;3:61-71.
8. Koshkina E, Koryakin S, Tsarev S. A study of the ''latent'' contingent of drug addicts by capture recapture method in the town of Chapayevsk of Samara Region in 2000-2001. Voprosy Narkologii (Addiction Issues) 2002;4:46-52.
9. Platt L, Hickman M, Rhodes T, et al. The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage. Addiction 2004;99:1430-8.
10. Platt L, Rhodes T, Hickman M, et al. Changes in HIV prevalence and risk among new injecting drug users in a Russian city of high HIV prevalence. JAIDS 2008;47:623-31.
11. Shaboltas AV, Toussova OV, Hoffman IF, et al. HIV prevalence, socio-demographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr 2006;41:657-63.
12. Kissin DM, Zapata L, Yorick R, et al. HIV seroprevalence in street youth, St. Petersburg, Russia. AIDS 2007;21:2333-40.
13. Kozlov A. HIV incidence and factors associated with HIV acquisition among injection drug users in St Petersburg, Russia. AIDS 2006;20:901-6.
14. Garnett GP, Garcia-Calleja JM, Rehle T, Gregson S. Behavioural data as an adjunct to HIV surveillance data. Sex Transm Infect 2006;82(Suppl 1):i57-62.
15. Diaz T, De Cock K, Brow T, et al. New strategies for HIV surveillance in resource-constrained settings: an overview. AIDS 2005;19(Suppl 2):S1-8.
16. UNAIDS/WHO. Guidelines for second generation hiv surveillance: the next decade. Geneva: Switzerland, 2000.
17. Zaba B, Slaymaker E, Urassa M, Boerma JT. The role of behavioral data in HIV surveillance. AIDS 2005;19(Suppl 2):S39-52.
18. Rehle T, Lazzari S, Dallabetta G, Asamoah-Odei E. Second-generation HIV surveillance: better data for decision-making. Bull World Health Organ 2004;82:121-7.
19. McGarrigle CA, Fenton KA, Gill ON, et al. Behavioural surveillance: the value of national coordination. STI 2002;78:398-405.
20. Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depen 1997;51:253-63.
21. Iguchi MY, Bux DA Jr. Reduced probability of HIV infection among crack cocaine - using injection drug users. AJPH 1997;87:1008-12.
22. Bluthenthal RN, Do DP, Finch B, et al. Community characteristics associated with HIV risk among injection drug users in the San Francisco Bay Area: a multilevel analysis. J Urban Health 2007;84:653-66.
23. Anderson MR, May RM. Infectious diseases of humans: dynamics and control, 1st edn. Oxford: Oxford Science Publications, 1991.
24. Hope DV, Judd A, Hickman M, et al. HIV prevalence among injecting drug users in England and Wales 1990-2003: evidence for increased transmission in recent years. AIDS 2005;19:1207-14.
25. Farrington CP. Modelling forces of infection for measles, mumps and rubella. Stat Med 1990;9:953-67.
26. Sutton AJ, Gay NJ, Edmunds WJ, et al. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. BMC Infect Dis 2006;6:93.
27. UNAIDS/WHO. Initiating second generation hiv surveillance systems: practical guidelines. Geneva: Switzerland, 2002.
28. Platt L, Rhodes T, Judd A, et al. Effects of sex work on the prevalence of syphilis among injection drug users in 3 Russian cities. AJPH 2007;97:478-85.
29. Hser Y-I, Hoffman V, Grella C, et al. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatr 2001;58:503-8.
30. Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug Alcohol Depend 2006;83:147-56.
31. Heimer R, Barbour R, Shaboltas AV, et al. Spatial distribution of HIV prevalence and incidence among injection drugs users in St Petersburg: implications for HIV transmission. AIDS 2008;22:123-30.
32. Rhodes T, Sarang A, Bobrik A, et al. HIV transmission and HIV prevention associated with injecting drug use in the Russian Federation. IJDP 2004;15:39-54.
33. Reilley B. Injecting drug use and HIV in Moscow: results of a survey. J Drug Issues 2000;30:305-22.
34. Dehne K, Kobyshcha Y. The HIV epidemic in Central and Eastern Europe Update 2000 2000.
35. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet 2001;357:1397-401.
36. Wood E, Schachar J, Li K, et al. Sex trade involvement is associated with elevated HIV incidence among injection drug users in Vancouver. Addict Res Theory 2007;15:321-5.
37. Weber AE, Boivin J-F, Blais L, et al. HIV risk profile and prostitution among female street youths. J Urban Health Bull N Y Acad Med 2002;79:525-33.
38. Spittal P, Bruneau J, Craib KJP, et al. Surviving the sex trade: a comparison of HIV risk behaviours among street-involved women in two Canadian cities who inject drugs. AIDS Care 2003;15:187-95.
39. Platt L, Rhodes T, Lowndes CM, et al. The impact of gender and sex work on sexual and injecting risk behaviours and their association with HIV positivity amongst injecting drug users in an HIV epidemic in Togliatti City, Russian Federation. STD 2005;32:605-12.
40. Smyth BP, Barry J, Keenan E. Irish injecting drug users and hepatitis C: the importance of the social context of injecting. Int J Epidemiol 2005;34:166-72.
41. Wodak A, Crofts N. Once more unto the breach: controlling hepatitis C in injecting drug users. Addiction 1996;91:181-4.
42. Taylor A, Fleming A, Rutherford J, Goldberg D. Examining the injecting practices of injecting drug users in Scotland. Edinburgh: Substance Misuse Division: Scottish Executive, 2004.